Global named patient use program of afatinib in advanced non-small-cell lung carcinoma patients who progressed following prior therapies

Future Oncology, Ahead of Print.

Source: Future Oncology - January 29, 2018 Category: Cancer & Oncology Authors: Federico Cappuzzo Ross Soo Maximilian Hochmair Martin Schuler Kwok Chi Lam Gerd Stehle Agnieszka Cseh Robert M Lorence Stephan Linden Nicole D Forman Wolfgang Hilbe Abdul Rahman Jazieh Chun-Ming Tsai Source Type: research